Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2016 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med. 2022 Feb 10;386(6):556-567. doi: 10.1056/NEJMoa2112651.
N Engl J Med. 2022.
PMID: 35139274
Clinical Trial.
Start strong or switch? Adjuvant endocrine strategies for postmenopausal women with hormone-sensitive breast cancer.
Tusquets Trías de Bes I, Tormo SS, Mestres JA.
Tusquets Trías de Bes I, et al. Among authors: mestres ja.
Biomed Pharmacother. 2009 Jan;63(1):1-10. doi: 10.1016/j.biopha.2008.04.005. Epub 2008 May 16.
Biomed Pharmacother. 2009.
PMID: 18539426
Review.
Item in Clipboard
Defining the optimal sequence for the systemic treatment of metastatic breast cancer.
Mestres JA, iMolins AB, Martínez LC, López-Muñiz JI, Gil EC, de Juan Ferré A, Del Barco Berrón S, Pérez YF, Mata JG, Palomo AG, Gregori JG, Pardo PG, Mañas JJ, Hernández AL, de Dueñas EM, Jáñez NM, Murillo SM, Bofill JS, Auñón PZ, Sanchez-Rovira P.
Mestres JA, et al.
Clin Transl Oncol. 2017 Feb;19(2):149-161. doi: 10.1007/s12094-016-1520-2. Epub 2016 Jun 17.
Clin Transl Oncol. 2017.
PMID: 27314861
Free PMC article.
Item in Clipboard
Cite
Cite